NASDAQ:CLXT - Calyxt Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$17.67 +0.29 (+1.67 %)
(As of 08/19/2018 11:16 AM ET)
Previous Close$17.67
Today's Range$17.1710 - $17.76
52-Week Range$11.80 - $31.89
Volume65,969 shs
Average Volume85,465 shs
Market Capitalization$566.39 million
P/E Ratio-15.78
Dividend YieldN/A
BetaN/A
Calyxt logoCalyxt, Inc., a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, enhanced oil composition and herbicide tolerant canola, enhanced quality and herbicide tolerant alfalfa, late blight resistant potatoes, and cold storable/reduced browning potatoes, as well as enhanced protein composition, drought tolerant, herbicide tolerant, and enhanced yield soybeans. The Company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was founded in 2010 and is headquartered in New Brighton, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.

Receive CLXT News and Ratings via Email

Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Agricultural chemicals
Sub-IndustryN/A
SectorConsumer Staples
SymbolNASDAQ:CLXT
CUSIPN/A
Phone651-683-2807

Debt

Debt-to-Equity Ratio0.16
Current Ratio21.27
Quick Ratio21.27

Price-To-Earnings

Trailing P/E Ratio-15.78
Forward P/E Ratio-17.32
P/E GrowthN/A

Sales & Book Value

Annual Sales$510,000.00
Price / Sales1,120.83
Cash FlowN/A
Price / CashN/A
Book Value$2.08 per share
Price / Book8.50

Profitability

EPS (Most Recent Fiscal Year)($1.12)
Net Income$-25,980,000.00
Net Margins-7,253.78%
Return on Equity-45.34%
Return on Assets-36.39%

Miscellaneous

Employees35
Outstanding Shares32,350,000
Market Cap$566.39 million

Calyxt (NASDAQ:CLXT) Frequently Asked Questions

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

How were Calyxt's earnings last quarter?

Calyxt Inc (NASDAQ:CLXT) announced its earnings results on Wednesday, August, 1st. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.22) by $0.04. The company earned $0.20 million during the quarter, compared to analysts' expectations of $0.10 million. Calyxt had a negative net margin of 7,253.78% and a negative return on equity of 45.34%. View Calyxt's Earnings History.

When is Calyxt's next earnings date?

Calyxt is scheduled to release their next quarterly earnings announcement on Monday, November, 12th 2018. View Earnings Estimates for Calyxt.

What price target have analysts set for CLXT?

5 analysts have issued 12 month target prices for Calyxt's shares. Their forecasts range from $22.00 to $34.25. On average, they anticipate Calyxt's share price to reach $29.05 in the next year. This suggests a possible upside of 64.4% from the stock's current price. View Analyst Price Targets for Calyxt.

What is the consensus analysts' recommendation for Calyxt?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Calyxt in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Calyxt.

What are Wall Street analysts saying about Calyxt stock?

Here are some recent quotes from research analysts about Calyxt stock:
  • 1. Jefferies Financial Group Inc analysts commented, "CLXT announced in an 8-K filing that CFO Bryan Corkal has resigned from the company effective immediately. While the announcement was unexpected, we believe it was a personal decision & not the result of any disagreement with the company or a sign of any operational / financial issues. In fact, we are incrementally positive on near term fundamentals following meetings with mgmt earlier this week." (6/22/2018)
  • 2. According to Zacks Investment Research, "Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well as offers fat saturation and gluten reduction in soybean oil and wheat. Calyxt, Inc. is based in New Brighton, United States. " (5/28/2018)

Are investors shorting Calyxt?

Calyxt saw a decrease in short interest during the month of July. As of July 13th, there was short interest totalling 923,320 shares, a decrease of 24.0% from the June 29th total of 1,214,454 shares. Based on an average trading volume of 79,477 shares, the days-to-cover ratio is presently 11.6 days. Approximately 10.1% of the shares of the company are sold short. View Calyxt's Current Options Chain.

Who are some of Calyxt's key competitors?

Who are Calyxt's key executives?

Calyxt's management team includes the folowing people:
  • Mr. Federico A. Tripodi, Chief Exec. Officer (Age 41)
  • Dr. Daniel Voytas Ph.D., Founder & Chief Science Officer (Age 55)
  • Mr. Eric Dutang, Interim CFO & Principal Accounting Officer (Age 44)
  • Simon Harnest, VP of Fin. & Investor Relations
  • Ms. Jennifer Moore, VP of Communications

When did Calyxt IPO?

(CLXT) raised $101 million in an IPO on Thursday, July 20th 2017. The company issued 6,100,000 shares at a price of $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities served as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

Has Calyxt been receiving favorable news coverage?

Media coverage about CLXT stock has been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research firm scores the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Calyxt earned a news impact score of 0.17 on Accern's scale. They also gave news articles about the company an impact score of 48.57 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View Recent Headlines for Calyxt.

Who are Calyxt's major shareholders?

Calyxt's stock is owned by a number of of retail and institutional investors. Top institutional investors include FMR LLC (14.84%), BlackRock Inc. (2.27%), Point72 Asset Management L.P. (0.93%), Columbus Hill Capital Management L.P. (0.52%), Laurion Capital Management LP (0.19%) and Perkins Capital Management Inc. (0.16%). Company insiders that own Calyxt stock include Alain Godard, Andre Choulika, Bryan WJ Corkal, Daniel F Voytas, Federico A Tripodi, Glenn R Bowers, Manoj Sahoo, Michel Arbadji, Philippe Dumont and SA Cellectis. View Institutional Ownership Trends for Calyxt.

Which institutional investors are selling Calyxt stock?

CLXT stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp. Company insiders that have sold Calyxt company stock in the last year include Alain Godard, Andre Choulika, Bryan WJ Corkal, Daniel F Voytas, Federico A Tripodi, Glenn R Bowers, Manoj Sahoo and Michel Arbadji. View Insider Buying and Selling for Calyxt.

Which institutional investors are buying Calyxt stock?

CLXT stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Point72 Asset Management L.P., Columbus Hill Capital Management L.P., BlackRock Inc., Laurion Capital Management LP, Perkins Capital Management Inc., Millennium Management LLC and Citadel Advisors LLC. Company insiders that have bought Calyxt stock in the last two years include Philippe Dumont and SA Cellectis. View Insider Buying and Selling for Calyxt.

How do I buy shares of Calyxt?

Shares of CLXT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Calyxt's stock price today?

One share of CLXT stock can currently be purchased for approximately $17.67.

How big of a company is Calyxt?

Calyxt has a market capitalization of $566.39 million and generates $510,000.00 in revenue each year. The company earns $-25,980,000.00 in net income (profit) each year or ($1.12) on an earnings per share basis. Calyxt employs 35 workers across the globe.

How can I contact Calyxt?

Calyxt's mailing address is 2800 MOUNT RIDGE ROAD, ROSEVILLE MN, 55113. The company can be reached via phone at 651-683-2807 or via email at [email protected]


MarketBeat Community Rating for Calyxt (NASDAQ CLXT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  131 (Vote Outperform)
Underperform Votes:  124 (Vote Underperform)
Total Votes:  255
MarketBeat's community ratings are surveys of what our community members think about Calyxt and other stocks. Vote "Outperform" if you believe CLXT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLXT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/19/2018 by MarketBeat.com Staff

Featured Article: Analyst Ratings

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.